Dr Mariam Jamal-Hanjani talks about the The lung TRACERx study, a prospective study of patients with primary non-small cell lung cancer, which through multi-region genetic sequencing and longitudinal tissue and blood sampling, aims to define the evolutionary pathways of lung cancer from diagnosis to relapse.
Ещё видео!